It has been demonstrated that interaction between the elevated anti-RgpB IgG levels and the HLA–DRB1 SE was only detected in ACPA-positive RA patients [117], supporting a role for this genetic variation in the response to citrullinated antigens. The gene discussed is HLA-DRB1; the disease is rheumatoid arthritis.